Literature DB >> 35390043

Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study.

Raj G Kumar1, Dmitry Esterov2, Rachel Sayko Adams3,4, John D Corrigan5, Shannon B Juengst6,7, Nancy D Chiaravalloti8,9, Belinda Yew1, Laura E Dreer10,11, Kristen Dams-O'Connor1,12.   

Abstract

OBJECTIVE: To evaluate the impact of COVID-19 pandemic exposure on changes in alcohol use and mood from years 1 to 2 after traumatic brain injury (TBI).
METHODS: We used a difference-in-difference (DiD) study design to analyze data from 1,059 individuals with moderate-to-severe TBI enrolled in the TBI Model Systems (TBIMS) National Database. We defined COVID-19 pandemic exposure as participants who received their year 1 post-injury interviews prior to January 1, 2020, and their year 2 interview between April 1, 2020 and January 15, 2021. Pandemic-unexposed participants had both year 1 and 2 follow-up interviews before January 1, 2020. We measured current alcohol use as any past month alcohol use, average number of drinks per drinking occasion, and past month binge drinking. We measured depression symptoms using Patient Health Questionnaire-9, and anxiety symptoms using the Generalized Anxiety Disorder-7.
RESULTS: We found persons with TBI exposed to the pandemic had greater increases in the average number of drinks per occasion from year 1 to 2 post-injury compared to pandemic-unexposed individuals (β = 0.36, 95% CI: 0.16, 0.57, p = 0.001), with males, adults <65 years old, and Black and Hispanic subgroups showing the greatest increases in consumption. Though average consumption was elevated, changes in rates of any alcohol use or binge drinking by pandemic exposure were not observed. Overall, there were no significant changes in depressive and anxiety symptoms over time between pandemic exposed and unexposed groups; however, pandemic-exposed Hispanics with TBI reported significant increases in anxiety symptoms from year-1 to year-2 post-injury compared to pandemic-unexposed Hispanics (β = 2.35, 95% CI: 0.25, 4.47, p = 0.028).
CONCLUSION: Among persons living with TBI, those exposed to the pandemic had significant increases in average alcohol consumption. Pandemic-exposed Hispanics with TBI had large elevations in anxiety symptoms, perhaps reflecting health inequities exacerbated by the pandemic, and suggesting a need for targeted monitoring of psychosocial distress.

Entities:  

Mesh:

Year:  2022        PMID: 35390043      PMCID: PMC8989351          DOI: 10.1371/journal.pone.0266422

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

The coronavirus disease-2019 (COVID-19) pandemic has resulted in widespread societal consequences, including death, strained healthcare systems, and tremendous economic disruption. In addition to the direct sequelae from infection, more people worldwide are reporting increased psychological distress [1, 2] and alcohol use [3, 4] during the pandemic. Studies of U.S. populations have found elevated distress [5], with up to a third of individuals meeting criteria for depressive or anxiety disorders during the pandemic [6, 7]. Moreover, greater psychological distress has been associated with more alcohol use [8], with correlations found between increased binge drinking during the pandemic and concomitant depressive symptoms [9]. Individuals with disabilities have historically faced barriers to accessing healthcare, resulting in health inequity, particularly among racial/ethnic minority groups [10]. The COVID-19 pandemic has magnified these longstanding inequities [11]; persons with disabilities are at higher risk of serious illness secondary to underlying neurologic conditions [12, 13] and have more difficulty engaging in COVID-19 preventative measures [14]. Persons with traumatic brain injury (TBI) represent an estimated 11.4 million persons with disability [15] who may be particularly affected by the pandemic, though currently only one cross-sectional study exists on how the COVID-19 pandemic has affected TBI survivors [16]. People who have incurred a TBI experience higher rates of depression [17-19] and anxiety [20-22] relative to individuals without a TBI. One large TBI study found cumulative prevalence of any psychiatric diagnosis (including depression, anxiety, and substance use disorders) was between 30–50% [23]. Presence of depression, anxiety, and/or at-risk substance use (including alcohol) has been linked to poorer physical, cognitive, and functional outcomes post-TBI [24-26]. It is unknown if the COVID-19 pandemic has exacerbated at-risk alcohol use or mood disorders among individuals with TBI. Given the high base rates of alcohol use and mood disorders among persons with TBI, distinction between “typical” TBI trajectory and pandemic-induced changes is necessary for any causal interpretation of the impact of the pandemic. Using a difference-in-difference (DiD) analytic approach, the present study aimed to elucidate the impact of the COVID-19 pandemic on alcohol use, depressive and anxiety symptoms among individuals living with TBI. In addition, given emerging evidence of health disparities [27, 28] and racial/ethnic differences in alcohol use and psychological distress during the pandemic [4, 5, 29], we evaluated whether the pandemic differentially affected demographic subgroups with TBI.

Methods

Participants

We drew our sample from the Traumatic Brain Injury Model Systems (TBIMS) National Database. This longitudinal database follows persons with a moderate-to-severe TBI at 1, 2, 5, and every subsequent 5 years after injury until death, 16+ years old, have sustained a moderate or severe TBI, and received inpatient rehabilitation at a TBIMS center. TBIMS participants provide informed consent directly or by proxy, and the study is overseen by each TBIMS center’s institutional review board. For the current study, we selected participants, or their proxies, who had completed year 1 (Y1) and year 2 (Y2) post-injury follow-up interviews between October 2, 2017 and January 15, 2021. We defined our primary study exposure, “pandemic-exposed”, as participants with TBI who completed their Y1 post-injury interview before January 1, 2020 and their Y2 interview during the COVID-19 pandemic; and “unexposed” as those who completed both Y1 and Y2 interviews before January 1, 2020. We operationally defined the start of the pandemic as April 1, 2020, as this conservatively represented a point in time by which most regions of the U.S. were impacted by the pandemic. January 1, 2020-March 30, 2020 was considered an ambiguous period with regard to pandemic exposure; participants interviewed during this period were excluded for the purposes of our analyses. Thus, there were 1,059 participants with eligible follow-up interviews. Of these, n = 694 (66%) were pandemic-unexposed and n = 365 (34%) were pandemic-exposed (Fig 1 for the timeline of Y1 and Y2 interview dates for pandemic-unexposed and pandemic-exposed participants). We also provide a flow diagram showing the derivation of the analytic sample in Fig 2. The sample with PHQ-9 and GAD-7 was lower than the sample with alcohol use variables because mood measures could only be completed by participants with TBI, while alcohol use could be reported by either participant or proxy.
Fig 1

Timeline of COVID-19 pandemic exposure groups.

We created two, mutually-exclusive pandemic exposure groups from Y1 and Y2 post-TBI data from the TBIMS National Database. The pandemic unexposed group had both their Y1 and Y2 interviews prior to January 1, 2020. While, the pandemic exposed group had their Y1 interview prior to January 1, 2020, and their Y2 interview between April 1st, 2020 and January 15th, 2021.

Fig 2

Study flow diagram.

Derivation of analytic sample for alcohol use and mood variables.

Timeline of COVID-19 pandemic exposure groups.

We created two, mutually-exclusive pandemic exposure groups from Y1 and Y2 post-TBI data from the TBIMS National Database. The pandemic unexposed group had both their Y1 and Y2 interviews prior to January 1, 2020. While, the pandemic exposed group had their Y1 interview prior to January 1, 2020, and their Y2 interview between April 1st, 2020 and January 15th, 2021.

Study flow diagram.

Derivation of analytic sample for alcohol use and mood variables.

Measures

Alcohol use

We determined alcohol use by asking participants (or their proxy) if they (the participant) had at least one drink in the month prior to the interview and the number of days per week or month these beverages were consumed. For those who reported drinking, they were asked how many drinks on average were ingested on days they drank. A ‘drink’ was operationally defined as one can or bottle of beer, glass of wine, can or bottle of wine cooler, cocktail, or shot of liquor. In accordance with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [30] definition of binge drinking, participants (or their proxy) were asked how many times during the past month they consumed 5+ drinks (males) or 4+ drinks (females) on one occasion. From these questions, we constructed the following outcomes: past month any drinking (y/n), average number of drinks per drinking occasion, and past month binge drinking (y/n).

Depression

We used the Patient Health Questionnaire-9 (PHQ-9) to assess depressive symptom severity. We calculated a total score by summing each of the PHQ-9 items (range 0–27) with higher scores indicating greater depressive symptomatology. The criterion, construct, and external validity of the PHQ-9 have been well established using large samples from a range of patient populations including individuals with moderate-severe TBI [19, 31, 32].

Anxiety

We measured anxiety symptom severity using the Generalized Anxiety Disorder 7-item scale (GAD-7). The GAD-7 is a self-report screening questionnaire of generalized anxiety symptom severity [33]. We calculated a total score by summing each of the GAD-7 items (range 0–21) with higher scores indicating the presence of greater anxiety symptoms.

Covariates

We included the following sociodemographic covariates: age at injury, racial/ethnic identity, educational attainment, and primary rehabilitation payor source. We considered these injury-related characteristics: mechanism of injury, time to follow motor commands, time until emergence of post-traumatic amnesia, and pre-index TBI history (i.e., injuries prior to the incident TBI that qualified the individual for TBIMS participation). We included the following clinical characteristics: acute and rehabilitation lengths of stay, cranial surgery status, residential status after rehabilitation discharge, and Functional Independence Measure (FIM) scores at rehabilitation discharge.

Statistical analysis

We used the quasi-experimental DiD design for this secondary analysis of the TBIMS National Database. DiD models are a well-established methodology used in public health, economics, and program evaluation [34-36]. This method compares longitudinal panel data between an exposed group and a counterfactual, unexposed group [36]. We constructed a series of DiD models using longitudinal generalized estimating equation (GEE) regression for all outcomes (alcohol use, depressive and anxiety symptoms), which facilitate estimation of population-average marginal effects while accounting for within-subject correlation of repeated observations from the same participant. Each model included a DiD coefficient, a follow-up period by pandemic exposure interaction representing differences in outcome scores over time modified by pandemic status. We adjusted GEE models for the covariates age, sex, race, and time to follow commands. For any alcohol use and binge drinking outcomes, we used GEE models with a binary distribution and logit link. For average number of drinks, we used GEE models with a negative binomial distribution with log link. For continuous outcomes of depressive symptoms (PHQ-9 total) and anxiety symptoms (GAD-7 total), we used GEE models with a Gaussian distribution and identity link. For all models, we used the margins and marginsplot commands in STATA 16.1 [37] to plot the predictions from the GEE model fit by pandemic status and follow-up period to illustrate the DiD trend for each outcome.

Subgroup analyses

We conducted pre-specified subgroup analyses by age (± 65 years old), sex, and race/ethnicity (White, Black, and Hispanic ethnicity). For Hispanic subgroup analyses, we included participants if they identified as Hispanic on the race/ethnicity question and/or a separate TBIMS question about Hispanic origin [38]. For each subgroup, we ran the same GEE models as primary analysis that included the follow-up period by pandemic exposure interaction, and adjusted for the same covariates (except those directly stratified on). For age-stratified models (± 65 years old), we controlled for chronological age to adjust for any residual confounding.

Checking assumptions and biases

There are fundamental assumptions underlying DiD models to facilitate causal interpretation [36]. Detailed explanation of our methods, which used historical TBIMS data from 2015–2016 to check the assumption of parallel trend, are provided in Briefly, this assumption states that, in the absence of exposure, the exposed and unexposed groups would follow the same trajectory of outcome. Of note, the parallel trend assumption does not presuppose that exposure groups be balanced on outcome variables at baseline (e.g., Y1). We also compared those with Y1 data and missing Y2 data to the analytic sample to evaluate any potential selection biases due to attrition at Y2.

Sensitivity analyses

We conducted sensitivity analyses of the primary models for any alcohol use, average number of drinks, and binge drinking by excluding persons who were pre-injury alcohol abstainers to test whether conclusions were similar among a subsample of pre-injury drinkers.

Results

Sample characteristics by exposure status

The sample consisted of 1,059 participants with moderate-severe TBI (n = 694 pandemic-unexposed; n = 365 pandemic-exposed) (see . The pandemic-exposed group was largely similar to the pandemic-unexposed group in demographic, injury, and clinical characteristics. Abbreviations: Glasgow Coma Scale, GCS; Time to Follow Commands, TFC, Post-traumatic amnesia, PTA; Functional Independence Measure, FIM. *statistically significant at α = 0.05.

Evaluating model assumptions and potential biases

Historical TBIMS data provided us with reasonable confidence that parallel trend assumptions were satisfied for all outcomes in our primary sample and all tested subgroups (. Those lost to follow-up were slightly older, more often had public insurance, more likely injured in a fall, were less likely to have a pre-index TBI history, and had lower FIM Cognitive scores at inpatient rehabilitation discharge than those followed. However, those lost to follow-up did not significantly differ from the analytic sample on any alcohol use or mood variables at Y1 post-injury ().

Difference-in-difference models: Primary analysis

For alcohol use, pandemic-exposed individuals with TBI reported greater increases in their average quantity of drinks per occasion from Y1 to Y2 post-injury compared to the pandemic-unexposed group (β = 0.36, 95% CI: 0.16, 0.57, p = 0.001; see ). There was insufficient evidence that probability of any alcohol use in the last month (β = 0.19, 95% CI: -0.98, 0.46, p = 0.167) and binge drinking in the last month (β = 0.03, 95% CI: -0.28, 0.54, p = 0.903) varied over time between exposure groups (see ). There was insufficient evidence of a difference in depressive symptoms (β = 0.04, 95% CI: -0.76, 0.84, p = 0.930) and anxiety symptoms (β = 0.52, 95% CI: -0.20, 1.25, p = 0.158) over time by pandemic exposure (see ).

Difference-in-difference plots of year 1 and year 2 mood and alcohol use by COVID-19 pandemic status (primary analysis).

(A) Y1 and Y2 model-fitted values for probability of any alcohol use in the last 30 days by pandemic status (interaction p-value = 0.167). (B) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status (interaction p-value = 0.001). (C) Y1 and Y2 model-fitted values for probability of any binge drinking in the last 30 days by pandemic status (interaction p-value = 0.903). (D) Y1 and Y2 model-fitted values for PHQ-9 total score by pandemic status (interaction p-value = 0.930). (E) Y1 and Y2 model-fitted values for GAD-7 total score by pandemic status (interaction p-value = 0.158).

Difference-in-difference plots of year 1 and year 2 mood by COVID-19 pandemic status (primary analysis).

(A) Y1 and Y2 model-fitted values for PHQ-9 total score by pandemic status (interaction p-value = 0.930). (B) Y1 and Y2 model-fitted values for GAD-7 total score by pandemic status (interaction p-value = 0.158). Abbreviations: Patient Health Questionnaire-9, PHQ-9; Generalized Anxiety Disorder-7, GAD-7; Difference-in- Difference, DiD ¥Descriptive measure, not model-based or adjusted for covariates ┼Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with Gaussian distribution and identity link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in PHQ-9/GAD-7 between pandemic exposed vs. unexposed from year 1 to year 2). §Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with binomial distribution and logit link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in any alcohol use/any binge drinking between pandemic exposed vs. unexposed from year 1 to year 2). €Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with negative binomial distribution and log link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in average number of drinks consumed per occasion between pandemic exposed vs. unexposed from year 1 to year 2).

Subgroup analyses among age, sex, and race/ethnicity subgroups

Pandemic-exposed persons who were less than 65 years old (β = 0.40, 95% CI: 0.17, 0.63, p = 0.001) and male (β = 0.39, 95% CI: 0.16, 0.62, p = 0.001) had greater increases in their average number of drinks per occasion from Y1 to Y2 post-injury compared to their pandemic-unexposed demographic counterparts (see Figs ).

Difference-in-difference plots of year 1 and year 2 average number of drink by COVID-19 pandemic status (among age subgroups).

(A) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among adults age ≥65 (interaction p-value = 0.474). (B) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among adults age <65 (interaction p-value = 0.001).

Difference-in-difference plots of year 1 and year 2 average number of drink by COVID-19 pandemic status (among sex subgroups).

(A) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among males (interaction p-value = 0.001). (B) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among females (interaction p-value = 0.401). Black (β = 0.60, 95% CI: 0.01, 1.19, p = 0.046) and Hispanic (β = 0.48, 95% CI: 0.01, 0.96, p = 0.045) pandemic-exposed participants had greater increases in their average number of drinks from Y1 to Y2 compared to their pandemic-unexposed counterparts (see ). There was insufficient evidence of change in probability of any alcohol use or past month binge drinking by pandemic status among any demographic subgroups ().

Difference-in-difference plots of year 1 and year 2 average number of drink by COVID-19 pandemic status (among race subgroups).

(A) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among Whites (interaction p-value = 0.089). (B) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among Blacks (interaction p-value = 0.046). (C) Y1 and Y2 model-fitted values for average number of drinks per occasion by pandemic status among Hispanics (interaction p-value = 0.045). For depressive symptoms, there was insufficient evidence that the DiD parameters were significant among any age, sex, or race/ethnicity subgroups (). For anxiety symptoms, among Hispanics, persons who were exposed to the pandemic had on average a 2.4-point greater increase in their GAD-7 total scores from Y1 to Y2 compared to changes over time among Hispanics unexposed to the pandemic (β = 2.35, 95% CI: 0.25, 4.47, p = 0.028). No other demographic subgroup had statistically significant differences in their anxiety scores over time by exposure group ().

Sensitivity analyses

Sensitivity analyses in which we excluded persons who were pre-injury alcohol abstainers showed findings largely similar to the primary alcohol use analyses ().

Discussion

Given that individuals with disabilities have been found to be differentially impacted by the COVID-19 pandemic [12-14], individuals with moderate-to-severe TBI may be susceptible to direct and/or indirect effects of the COVID-19 pandemic. However, few studies to date have investigated how the pandemic has affected persons with TBI. The current study used a novel quasi-experimental DiD design to evaluate how alcohol use and mood among individuals with TBI has changed as a result of the pandemic, including an evaluation of the pandemic’s impact on demographic subgroups. Our data indicated that the average number of drinks per occasion increased more from Y1 to Y2 post-injury among pandemic-exposed persons with TBI compared to those unexposed. The largest increases were seen among males, persons under 65 years old, and Black or Hispanic racial/ethnic minorities. We did not find evidence of differences in the rate of engaging in any alcohol use or past month binge drinking from Y1 to Y2 by pandemic exposure. This is consistent with research [39] from the early months of the pandemic which found that adults consumed more drinks per day in April 2020 compared to February 2020; yet, unlike this prior study, we did not observe increases in binge drinking during the pandemic for persons with moderate-to-severe TBI. Our study findings suggest factors associated with the pandemic and the context in which people were drinking may have facilitated increases in the quantity of drinks consumed during a typical drinking occasion. We speculate these changes reflect a convergence of factors such as social distancing measures during the pandemic that resulted in more drinking at home without worrying about driving home safely, purchasing alcohol in larger quantities due to availability concerns or to reduce shopping trips during the pandemic, or relaxing of state alcohol purchasing policies during the pandemic (e.g., increases in alcohol delivery options, restaurants being allowed to provide take-home alcohol with orders) [40]. While beyond the data that we had available in this study, it is likely some individuals had increases in occasions of solitary drinking during the pandemic due to the stay-at-home orders and most social activities being cancelled. Solitary drinking has unique risks for experiencing alcohol consequences or developing an alcohol use disorder [41, 42]. The psychological and social impact of living through the pandemic has been evident in studies in the general population [8, 43–47], and recent work has shown that one-third of individuals with TBI have identified mental health challenges and social isolation as key barriers to effective coping with the COVID-19 pandemic [16]. The Household Pulse Survey [48] found that anxiety has been particularly high among Hispanic adults and minority racial groups, and also for persons with a disability [48]. Data from the Centers for Disease Control and Prevention revealed that Hispanic adults reported more psychosocial distress than non-Hispanic adults during the pandemic due to instability in housing and food, and death of a loved one [45]. Similarly, in our study, we found that the pandemic resulted in increasing anxiety symptoms particularly among Hispanic persons with TBI. Though we did not observe population-level differences in mood by pandemic exposure in our study, mental health should still be continually monitored in TBI populations moving forward. Individuals with moderate-to-severe TBI already struggle with anxiety [49], loneliness [50], and limited social participation compared to non-injured peers [51, 52]. These daily challenges would likely only worsen during a global pandemic due to fear of contracting the virus and recommendations or mandates to limit in-person social interaction. Among the reasons for decreased socialization are difficulty navigating masked social interactions [16] and barriers to the use of on-line technology platforms [53, 54] for socialization. These new challenges, superimposed on the already existing challenges in this area faced by individuals with TBI, would only add to the mental health challenges characteristic of the COVID-19 pandemic. The pattern of subgroup findings reported here––specifically, that the largest increases in average drinks per occasion were among Black or Hispanic racial/ethnic minorities, together with substantial increases in anxiety symptoms among Hispanic individuals exposed to the pandemic––may suggest that factors other than the pandemic played a role in the differences observed. Previous research has found Black/non-Hispanic adults and Hispanic women have had the largest increases in alcohol consumption during the pandemic, consuming more drinks per day than White, non-Hispanic adults, with the exception of women with children under 5 years old [39]. And alcohol consumption is inextricably linked with anxiety [55]. The political and sociocultural climate in the U.S. during the pandemic can be characterized by political discord and heightened racial tensions, and it will be impossible to disentangle the relative contributions of multiple stressors on the results observed herein. However, the observation that racial and ethnic minorities with TBI who were exposed to the pandemic experienced greater increases in alcohol use and anxiety may reflect disproportionately detrimental ambient stress and related consequences during the time period studied. The TBIMS offers a unique opportunity to understand the impact of the pandemic on individuals with TBI because we have data on the same participants before and after pandemic and are able to compare this change to an unexposed comparison group with harmonized measures. However, there are some limitations in both the data available and our analysis approach. Though our binge drinking measure was consistent with NIAAA guidelines, we did not have information available in this study on alcohol use disorder nor, more generally, consequences of drinking. We were unable to determine whether participants had COVID-19, and did not have measures on the mediating psychosocial factors (e.g., loss of a loved one, discrimination) that may explain our results. The DiD approach requires non-missing data from Y1 and Y2, so it is possible that the most depressed/anxious individuals were not captured at Y2 due to higher attrition; however, this limitation is ameliorated by there being no significant differences in Y1 alcohol use and depression/anxiety between the analytic sample and those without Y2 data. Finally, consistent with other studies [27, 28, 45, 48], findings from our study highlight how systemic factors (e.g., access to healthcare and technology) affect individuals with TBI and from racial and ethnic minority groups. Though we did not have data available to measure these factors directly, this is an important area for future study.

Conclusions

The current findings indicating an increase in the number of drinks consumed on a typical drinking occasion and anxiety suggest we should monitor alcohol consumption and mental health among individuals with TBI as the pandemic unfolds. In particular, adherence to low-risk drinking guidelines [56] for individuals with TBI can help mitigate future risk for substance use disorders [57].

Parallel trend assumptions of difference-in-difference models.

(DOCX) Click here for additional data file.

Investigation of parallel trend historical analysis of alcohol use (overall sample).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis depression and anxiety (overall sample).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of any alcohol (age subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of any alcohol (sex subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of any alcohol (race/ethnicity subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of average number of drinks per occasion (age subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of average number of drinks per occasion (sex subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of average number of drinks per occasion (race/ethnicity subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of binge drinking (age subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of binge drinking (sex subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of binge drinking (race/ethnicity subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of depression (age subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of depression (sex subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of depression (race/ethnicity subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of anxiety (age subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of anxiety (sex subgroups).

(TIF) Click here for additional data file.

Investigation of parallel trend historical analysis of anxiety (race/ethnicity subgroups).

(TIF) Click here for additional data file.

Investigation of potential selection bias for completed year 2 follow-up after completed year 1 follow-up.

(DOCX) Click here for additional data file.

Subgroup difference-in-difference analyses of average number of drinks by pandemic exposure status.

(DOCX) Click here for additional data file.

Subgroup difference-in-difference analyses of any alcohol use in the last month by pandemic exposure status.

(DOCX) Click here for additional data file.

Subgroup difference-in-difference analyses of binge drinking in the last month by pandemic exposure status.

(DOCX) Click here for additional data file.

Subgroup difference-in-difference analyses of phq-9 by pandemic exposure status.

(DOCX) Click here for additional data file.

Subgroup difference-in-difference analyses of gad-7 by pandemic exposure status.

(DOCX) Click here for additional data file.

Sensitivity analysis of alcohol use outcomes excluding pre-injury abstainers.

(DOCX) Click here for additional data file. 3 Feb 2022
PONE-D-21-37809
Changes in Alcohol Use and Mood during the COVID-19 Pandemic among Individuals with Traumatic Brain Injury: A Difference-in-Difference Study
PLOS ONE Dear Dr. Kumar, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammad Farris Iman Leong Bin Abdullah, Dr Psych Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating in your Funding Statement: Dr. Dams-O’Connor, Dr. Kumar, and Dr. Yew’s effort were support in part by a grant from National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) to the Icahn School of Medicine at Mount Sinai (90DP0038 and 90DPTB0009). Dr. Kumar was also supported in part by a grant from the National Institute of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K99HD106060-01). Dr. Dams-O’Connor is also supported in part by a grant from the National Institute of Health’s National Institute on Neurological Disorders and Stroke (RF1NS115268). Dr. Dreer’s support was funded in part by a NIDILRR grant to the Department of Physical Medicine & Rehabilitation in the School of Medicine at the University of Alabama at Birmingham Rehabilitation, University of Alabama at Birmingham (NIDILRR: 90DPTB0015). Dr. Esterov’s support was funded in part by a NIDILRR grant to the Department of Physical Medicine and Rehabilitation at Mayo Clinic, (NIDILRR: 90DPTB0012-01-00). Dr. Chiaravalloti’s support was funded by a NIDILRR grant to Kessler Foundation (NIDILRR: 90DPTB0003). Dr. Corrigan’s effort was supported in part by a grant from NIDILRR to Ohio State University (90DPTB0001). Dr. Juengst’s effort was supported in part by a grant from NIDILRR to the University of Texas Southwestern Medical Center (90DPTB0013) and TIRR Memorial Hermann Hospital (90DPTB0016). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIH, NIDILRR, the Administration on Community Living, the U.S. Department of Health and Human Services, the U.S. Department of Veterans Affairs, and endorsement by the Federal Government should not be assumed. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. Thank you for stating the following financial disclosure: Dr. Dams-O’Connor, Dr. Kumar, and Dr. Yew’s effort were support in part by a grant from National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) to the Icahn School of Medicine at Mount Sinai (90DP0038 and 90DPTB0009). Dr. Kumar was also supported in part by a grant from the National Institute of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K99HD106060-01). Dr. Dams-O’Connor is also supported in part by a grant from the National Institute of Health’s National Institute on Neurological Disorders and Stroke (RF1NS115268). Dr. Dreer’s support was funded in part by a NIDILRR grant to the Department of Physical Medicine & Rehabilitation in the School of Medicine at the University of Alabama at Birmingham Rehabilitation, University of Alabama at Birmingham (NIDILRR: 90DPTB0015). Dr. Esterov’s support was funded in part by a NIDILRR grant to the Department of Physical Medicine and Rehabilitation at Mayo Clinic, (NIDILRR: 90DPTB0012-01-00). Dr. Chiaravalloti’s support was funded by a NIDILRR grant to Kessler Foundation (NIDILRR: 90DPTB0003). Dr. Corrigan’s effort was supported in part by a grant from NIDILRR to Ohio State University (90DPTB0001). Dr. Juengst’s effort was supported in part by a grant from NIDILRR to the University of Texas Southwestern Medical Center (90DPTB0013) and TIRR Memorial Hermann Hospital (90DPTB0016). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIH, NIDILRR, the Administration on Community Living, the U.S. Department of Health and Human Services, the U.S. Department of Veterans Affairs, and endorsement by the Federal Government should not be assumed. Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Competing Interests section: Dr. Adams consults for TIAG, in support of the National Intrepid Center of Excellence (NICOoE) at Walter Reed National Medical Center. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting analysis and obviously timely. I have only one significant comment and it is a criticism but something that should be discussed. In the data presented on the Y1-Y2 differences in number of drinks the significant DID seems to be mediated by both a larger number of Y2 drinks and a smaller number of Y1 for the pandemic exposed individuals. Is this apparent difference statistically significant, what could have caused it and would controlling for it reduce the effect of the pandemic? Reviewer #2: This manuscript uses a unique and large dataset in order to answer an important question - what is the impact of experiencing the COVID-19 pandemic on alcohol consumption and is this different for subgroups of people with known COVID-19 vulnerabilities? That cannot be overstated. However, there are a few concerns that I have with the manuscript that dampen enthusiasm. - The alcohol consumption measures are limited to drinks per occasion and binge drinking. Validated measures of alcohol consumption or an index of alcohol use disorder are not included in this dataset. This should be stated as a limitation in the discussion. - The 3rd paragraph of the discussion around the self-medication hypothesis is entirely and highly speculative given the data available and recommend removing entirely. I am not sure that perpetuation of a self-medication hypothesis in the substance use disorder field is helpful. - The mental health measures used necessitate changing references to anxiety and depression to anxiety and depression symptoms as they are not diagnostic in nature. - The data figures (3 and 4) are not legible and need to be improved. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
13 Feb 2022 Response to reviews: Reviewer #1: This is an interesting analysis and obviously timely. I have only one significant comment and it is a criticism but something that should be discussed. In the data presented on the Y1-Y2 differences in number of drinks the significant DID seems to be mediated by both a larger number of Y2 drinks and a smaller number of Y1 for the pandemic exposed individuals. Is this apparent difference statistically significant, what could have caused it and would controlling for it reduce the effect of the pandemic? RESPONSE: This reviewer raises an important question that our collaborative group discussed at length when devising our analytic strategy. We followed a rigorous methodology consistent with difference-in-difference analyses to test model assumptions as recommended by Wing et al. (2018). The main assumption with these models is the “parallel trend assumption” which presupposes that the trend over time observed in the unexposed group would have been observed in our exposed group had they not been exposed. We used historical data collected in the TBI Model Systems from 2015-2016 (i.e., preceding the timeframe of our analytic sample) to test our parallel trend assumption for the primary analyses and all subgroup analyses (see Supplemental Figures 1-17). The main parameter of interest in difference-in-difference analyses is the interaction term (β3) in the general equation below. E(Y) = β0 + β1(Pandemic Exposed) + β2(Time) + β3(Exposed*Time) + ɛ Crucially, while these longitudinal models do already account for the baseline main effects of exposure status (β1), it is not required that β1 be non-significant for there to be an observed difference between exposure groups over time (e.g., β3). Therefore, any small difference in average number of drinks at baseline (0.91 unexposed vs. 0.78 exposed) do not change the conclusions regarding the impact of the pandemic observed herein. To make this point clearer, we have now clarified in our Methods section that the parallel trend assumption does not presuppose that exposure groups be balanced with respect the outcome at baseline (p. 8 lines 205-208). We have also provided the reference below that provides further detail that may be of interest. Reference: Wing C, Simon K, Bello-Gomez RA. Designing difference in difference studies: best practices for public health policy research. Annual review of public health. 2018;39. Reviewer #2: This manuscript uses a unique and large dataset in order to answer an important question - what is the impact of experiencing the COVID-19 pandemic on alcohol consumption and is this different for subgroups of people with known COVID-19 vulnerabilities? That cannot be overstated. However, there are a few concerns that I have with the manuscript that dampen enthusiasm. - The alcohol consumption measures are limited to drinks per occasion and binge drinking. Validated measures of alcohol consumption or an index of alcohol use disorder are not included in this dataset. This should be stated as a limitation in the discussion. RESPONSE: We thank this reviewer for this comment to allow us the opportunity to clarify details on the strengths and limitations of our alcohol data collection in this study. In 2017, the TBIMS National Database changed their data collection protocol to be consistent with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines for binge drinking, which are 5+ drinks on an occasion for men, and 4+ drinks on an occasion for women. This NIAAA sex-specific binge drinking definition was applied in our full sample, which we have described in our methods section (p. 6 lines 149-151). That said, this reviewer’s point is well-taken, and unfortunately we did not have information available in this study on alcohol use disorder, nor measures related to consequences of drinking. We have now added these points as limitations in our discussion (p. 14 lines 360-362). - The 3rd paragraph of the discussion around the self-medication hypothesis is entirely and highly speculative given the data available and recommend removing entirely. I am not sure that perpetuation of a self-medication hypothesis in the substance use disorder field is helpful. RESPONSE: As suggested by the reviewer, we have removed discussion of the self-medication hypothesis in the discussion (p. 12 lines 307-310). - The mental health measures used necessitate changing references to anxiety and depression to anxiety and depression symptoms as they are not diagnostic in nature. RESPONSE: We thank this reviewer for this comment. We agree and have gone through our entire manuscript and made changes to the language such that anxiety and depression are now referred to as anxiety symptoms and depressive symptoms, respectively. - The data figures (3 and 4) are not legible and need to be improved. RESPONSE: We thank the reviewer for this feedback. We have now split up Figures 3 and 4 into multiple figures, which substantially reduces the number of panels in each figure. We have also enhanced the quality of each figure to further aid in legibility. Submitted filename: Response to reviews FINAL.docx Click here for additional data file. 21 Mar 2022 Changes in Alcohol Use and Mood during the COVID-19 Pandemic among Individuals with Traumatic Brain Injury: A Difference-in-Difference Study PONE-D-21-37809R1 Dear Dr. Kumar, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Samuel Wilkinson, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No 24 Mar 2022 PONE-D-21-37809R1 Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study Dear Dr. Kumar: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Samuel Wilkinson Academic Editor PLOS ONE
Table 1

Characteristics of sample by COVID-19 pandemic exposure.

Pandemic Unexposed (n = 694)Pandemic Exposed (n = 365)p-value
Demographic characteristics
Age at injury, Mean (SD)45.5 (20.1)47.3 (20.0)0.157
Sex, Men (%)519 (75.3%)265 (72.6%)0.335
Race, n (%)0.293
 White442 (63.7%)240 (65.9%)
 Black120 (17.3%)60 (16.5%)
 Hispanic99 (14.3%)40 (11.0%)
 Other33 (4.8%)24 (6.6%)
Education, n (%)0.353
 Less than HS144 (20.9%)85 (23.4%)
 HS+544 (79.1%)278 (76.6%)
Primary rehabilitation payor source, n (%)0.487
 Private insurance290 (42.2%)144 (39.6%)
 Medicare or Medicaid235 (34.2%)138 (37.9%)
 Other162 (23.6%)82 (22.5%)
Injury characteristics
Mechanism of injury, n (%)0.825
 Motor vehicle254 (37.0%)137 (37.6%)
 Fall247 (36.0%)138 (37.9%)
 Any violence50 (7.3%)24 (6.6%)
 Other136 (19.8%)65 (17.9%)
GCS score, Median (IQR)13 (6–15)13 (7–15)0.487
TFC (days), Median (IQR)1 (0.5–8)1 (0.5–5)0.008*
Duration of PTA (days), Median (IQR)19 (4–36)16 (4–34)0.317
Pre-index lifetime history of TBI, n (%)174 (25.3%)81 (22.4%)0.295
Clinical characteristics
Acute hospital length of stay, Mean (SD)19.8 (15.5)20.5 (20.0)0.507
Inpatient rehabilitation length of stay, Mean (SD)25.3 (27.3)23.7 (23.7)0.193
Craniotomy or craniectomy, n (%)174 (25.3%)95 (26.0%)0.794
FIM Motor at Rehabilitation discharge, Mean (SD)65.4 (18.0)65.2 (17.5)0.696
FIM Cognitive at Rehabilitation Discharge, Mean (SD)23.7 (6.5)23.8 (6.8)0.645
Residence after inpatient0.279
rehabilitation discharge, n (%)
 Private residence551 (80.2%)278 (76.2%)
 Nursing home/adult home13 (1.9%)10 (2.7%)
 Other123 (17.9%)77 (21.1%)

Abbreviations: Glasgow Coma Scale, GCS; Time to Follow Commands, TFC, Post-traumatic amnesia, PTA; Functional Independence Measure, FIM.

*statistically significant at α = 0.05.

Table 2

Difference-in difference analysis of alcohol use and mood by COVID-19 pandemic exposure status.

Outcome
Any alcohol use in the last monthCOVID-19 pandemic exposureFollow-up periodNcases¥ (%)DiD Parameter Estimate§ (95% CI)P-value
No (n = 652)Year 1245 (37.6%)0.19 (-0.08, 0.46)0.167
Year 2277 (42.5%)
Yes (n = 343)Year 1118 (34.4%)
Year 2149 (43.4%)
Average number of drinks per occasionCOVID-19 pandemic exposureFollow-up periodMean¥ (SE)DiD Parameter Estimate (95% CI)P-value
No (n = 638)Year 10.91 (1.83)0.36 (0.16, 0.57)0.001*
Year 21.00 (1.72)
Yes (n = 335)Year 10.78 (1.42)
Year 21.23 (2.11)
Any binge drinking in the last monthCOVID-19 pandemic exposureFollow-up periodNcases¥ (%)DiD Parameter Estimate§ (95% CI)P-value
No (n = 631)Year 163 (10.0%)0.03 (-0.48, 0.54)0.903
Year 277 (12.2%)
Yes (n = 337)Year 133 (9.8%)
Year 241 (12.2%)
PHQ-9COVID-19 pandemic exposureFollow-up periodMean¥ (SD)DiD Parameter Estimate (95% CI)P-value
No (n = 452)Year 15.34 (5.97)0.04 (-0.76, 0.84)0.930
Year 25.39 (5.63)
Yes (n = 253)Year 15.90 (6.04)
Year 26.06 (6.04)
GAD-7COVID-19 pandemic exposureFollow-up periodMean¥ (SE)DiD Parameter Estimate (95% CI)P-value
No (n = 459)Year 14.00 (5.37)0.52 (-0.20, 1.25)0.158
Year 24.00 (5.08)
Yes (n = 253)Year 14.14 (5.06)
Year 24.70 (5.13)

Abbreviations: Patient Health Questionnaire-9, PHQ-9; Generalized Anxiety Disorder-7, GAD-7; Difference-in- Difference, DiD

¥Descriptive measure, not model-based or adjusted for covariates

┼Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with Gaussian distribution and identity link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in PHQ-9/GAD-7 between pandemic exposed vs. unexposed from year 1 to year 2).

§Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with binomial distribution and logit link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in any alcohol use/any binge drinking between pandemic exposed vs. unexposed from year 1 to year 2).

€Estimate represents pandemic exposure*followup period interaction parameter estimate from GEE Model with negative binomial distribution and log link. The GEE model adjusted for age at injury, sex, race, and time to follow commands in days (interpreted as DiD in average number of drinks consumed per occasion between pandemic exposed vs. unexposed from year 1 to year 2).

  52 in total

1.  Characterizing computer-mediated communication, friendship, and social participation in adults with traumatic brain injury.

Authors:  Margaret A Flynn; Arianna Rigon; Rachel Kornfield; Bilge Mutlu; Melissa C Duff; Lyn S Turkstra
Journal:  Brain Inj       Date:  2019-05-17       Impact factor: 2.311

Review 2.  Traumatic brain injury and substance misuse: a systematic review of prevalence and outcomes research (1994-2004).

Authors:  Beth L Parry-Jones; Frances L Vaughan; W Miles Cox
Journal:  Neuropsychol Rehabil       Date:  2006-10       Impact factor: 2.868

3.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

4.  Psychiatric illness following traumatic brain injury in an adult health maintenance organization population.

Authors:  Jesse R Fann; Bart Burington; Alexandra Leonetti; Kenneth Jaffe; Wayne J Katon; Robert S Thompson
Journal:  Arch Gen Psychiatry       Date:  2004-01

5.  Prevalence of Drinking Within Low-Risk Guidelines During the First 2 Years After Inpatient Rehabilitation for Moderate or Severe Traumatic Brain Injury.

Authors:  Rachel Sayko Adams; Jessica M Ketchum; Risa Nakase-Richardson; Douglas I Katz; John D Corrigan
Journal:  Am J Phys Med Rehabil       Date:  2021-08-01       Impact factor: 3.412

6.  Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020.

Authors:  Lela R McKnight-Eily; Catherine A Okoro; Tara W Strine; Jorge Verlenden; NaTasha D Hollis; Rashid Njai; Elizabeth W Mitchell; Amy Board; Richard Puddy; Craig Thomas
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-05       Impact factor: 17.586

7.  Triple jeopardy: disabled people and the COVID-19 pandemic.

Authors:  Tom Shakespeare; Florence Ndagire; Queen E Seketi
Journal:  Lancet       Date:  2021-03-16       Impact factor: 79.321

8.  Trends in Anxiety and Depression Symptoms During the COVID-19 Pandemic: Results from the US Census Bureau's Household Pulse Survey.

Authors:  Christopher Cai; Steffie Woolhandler; David U Himmelstein; Adam Gaffney
Journal:  J Gen Intern Med       Date:  2021-04-14       Impact factor: 5.128

9.  Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US.

Authors:  Michael S Pollard; Joan S Tucker; Harold D Green
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  COVID-19 Home Confinement Negatively Impacts Social Participation and Life Satisfaction: A Worldwide Multicenter Study.

Authors:  Achraf Ammar; Hamdi Chtourou; Omar Boukhris; Khaled Trabelsi; Liwa Masmoudi; Michael Brach; Bassem Bouaziz; Ellen Bentlage; Daniella How; Mona Ahmed; Patrick Mueller; Notger Mueller; Hsen Hsouna; Asma Aloui; Omar Hammouda; Laisa Liane Paineiras-Domingos; Annemarie Braakman-Jansen; Christian Wrede; Sophia Bastoni; Carlos Soares Pernambuco; Leonardo Mataruna; Morteza Taheri; Khadijeh Irandoust; Aïmen Khacharem; Nicola L Bragazzi; Jana Strahler; Jad Adrian Washif; Albina Andreeva; Samira C Khoshnami; Evangelia Samara; Vasiliki Zisi; Parasanth Sankar; Waseem N Ahmed; Mohamed Romdhani; Jan Delhey; Stephen J Bailey; Nicholas T Bott; Faiez Gargouri; Lotfi Chaari; Hadj Batatia; Gamal Mohamed Ali; Osama Abdelkarim; Mohamed Jarraya; Kais El Abed; Nizar Souissi; Lisette Van Gemert-Pijnen; Bryan L Riemann; Laurel Riemann; Wassim Moalla; Jonathan Gómez-Raja; Monique Epstein; Robbert Sanderman; Sebastian Schulz; Achim Jerg; Ramzi Al-Horani; Taiysir Mansi; Mohamed Jmail; Fernando Barbosa; Fernando Ferreira-Santos; Boštjan Šimunič; Rado Pišot; Saša Pišot; Andrea Gaggioli; Piotr Zmijewski; Christian Apfelbacher; Jürgen Steinacker; Helmi Ben Saad; Jordan M Glenn; Karim Chamari; Tarak Driss; Anita Hoekelmann
Journal:  Int J Environ Res Public Health       Date:  2020-08-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.